Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.48)
# 2,389
Out of 5,122 analysts
26
Total ratings
52.63%
Success rate
13.1%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintains: Outperform | $19 → $23 | $18.98 | +21.18% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $29.93 | +83.76% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $24.66 | +25.71% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $6.63 | +88.54% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.38 | +334.78% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.68 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $13.51 | +85.05% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $3.18 | +7,447.17% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $38.98 | +105.23% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.86 | +235.28% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $3.69 | +550.41% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.55 | +78,331.37% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.35 | - | 1 | Sep 27, 2017 |
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $18.98
Upside: +21.18%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $29.93
Upside: +83.76%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $24.66
Upside: +25.71%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $6.63
Upside: +88.54%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.38
Upside: +334.78%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.68
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $13.51
Upside: +85.05%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.18
Upside: +7,447.17%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $38.98
Upside: +105.23%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.86
Upside: +235.28%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $3.69
Upside: +550.41%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.55
Upside: +78,331.37%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.35
Upside: -